ICH prepares for global quality implementation
The International Conference on Harmonization (ICH) has adopted pharmacopeial text annexes after a meeting of the steering committee and expert working groups last week.
The International Conference on Harmonization (ICH) has adopted pharmacopeial text annexes after a meeting of the steering committee and expert working groups last week.
Several annexes to ICH Q4B on pharmacopeial texts have been adopted. Three annexes 7 Dissolution, 9 Tablet Friability, and 10 Polyacrylamide Gel Electrophoresis all reached Step 4 of the harmonization process, according to an ICH press release. The annexes had just reached Step 3 (regulatory consultation and discussion) of the harmonization process during the past year, demonstrating international support for uniting the way pharmacopeial standards are used. Although ICH guidelines are not mandatory, the next step for these three annexes is to be reviewed and published by the regulatory bodies in the US, Europe, and Japan. Annex 11 Capillary Electrophoresis and Annex 12 Analytical Sieving to the Q4B guideline reached Step 2 (consensus by the six ICH parties) during the meeting.
Also of interest to the pharmaceutical manufacturers, ICH’s Quality Implementation Working Group, which is focusing on the quality trio (Q8 Pharmaceutical Development, Q9 Quality Risk Management, and Q10 Pharmaceutical Quality System), set a schedule for training workshops in each of the three ICH regions. "This training will consist of case studies representing the four phases of the life cycle of a pharmaceutical product," according the ICH release. The workshops will be held in Brussels in June 2010, in Washington, DC, in October 2010, and in Tokyo in November 2010.
Other highlights of the meeting: ICH S9 Nonclinical Evaluation of Anticancer Pharmaceuticals reached Step 4 of the harmonization process. ICH S6 Revision of Preclinical Safety Evaluation of Biotechnology-derived Pharmaceuticals reached Step 2. In addition, ICH safety experts held a day-long brainstorming session to discuss how to fill current gaps in safety guidelines.
The next ICH Steering Committee will be held in Europe in June 2010. The group meets twice every year.
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
Navigating Annex 1 for Early Phase Sterile Fill Finish in Clinical Supplies
November 21st 2024Stay compliant with Annex 1 for early phase sterile fill finish processes. Discover how to implement robust contamination control strategies, integrate isolator technology, and conduct integrity testing to meet stringent European Union standards. The guide provides a comprehensive look at key elements such as PUPSIT, critical zone controls, and monitoring and training for aseptic processes.
Your Ultimate Guide for CMC Testing Support for Gene and Cell Therapy
November 21st 2024Explore the complexities of gene and cell therapy development with our comprehensive guide to Chemistry, Manufacturing, and Controls (CMC) testing. Learn how our expertise ensures the safety, potency, and quality of advanced therapies, supporting your journey from product development through regulatory approval.
